Prospective surveillance of antibiotic use in the neonatal intensive care unit: Results from the SCOUT study

Pediatric Infectious Disease Journal

Volumn 34, Issue 3, 2015, Pages 267-272

  Cantey, Joseph B ^a   Wozniak, Phillip S ^a   Sánchez, Pablo J ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Neonate; Stewardship

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEPHALOSPORIN; GENTAMICIN; MEROPENEM; OXACILLIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; AXENIC CULTURE; DRUG USE; ELECTRONIC MEDICAL RECORD; EVALUATION STUDY; FEMALE; GESTATIONAL AGE; GROUP B STREPTOCOCCAL INFECTION; HEART DISEASE; HUMAN; INFANT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEPSIS; TREATMENT DURATION; TREATMENT WITHDRAWAL; HEALTH SURVEY; MICROBIOLOGY; NEWBORN; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PROSPECTIVE STUDIES; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; SEPSIS;

EID: 84924153364     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000542     Document Type: Article

References (52)

1. Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006;117:1979-1987.
2. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, et al.; Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005;24:766-773.
3. Tsai MH, Chu SM, Hsu JF, et al. Risk factors and outcomes for mul-tidrug-resistant Gram-negative bacteremia in the NICU. Pediatrics. 2014;133:e322-e329.
4. de Man P, Verhoeven BA, Verbrugh HA, et al. An antibiotic policy to prevent emergence of resistant bacilli. Lancet. 2000;355:973-978.
5. Cotten CM, McDonald S, Stoll B, et al.; National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118:717-722.
6. Cotten CM, Taylor S, Stoll B, et al.; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics. 2009;123:58-66.
7. Kuppala VS, Meinzen-Derr J, Morrow AL, et al. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr. 2011;159:720-725.
8. Saiman L, Ludington E, Dawson JD, et al.; National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119-1124.
9. Alexander VN, Northrup V, Bizzarro MJ. Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr. 2011;159:392-397.
10. Lee JH, Hornik CP, Benjamin DK Jr, et al. Risk factors for invasive candidiasis in infants >1500 g birth weight. Pediatr Infect Dis J. 2013;32:222-226.
11. Cantey JB, Patel SJ. Antimicrobial stewardship in the NICU. Infect Dis Clin North Am. 2014;28:247-261.
12. Dellit TH, Owens RC, McGowan JE Jr, et al.; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177.
13. Patel SJ, Rosen E, Zaoutis T, et al. Neonatologists' perceptions of antimicrobial resistance and stewardship in neonatal intensive care units. Infect Control Hosp Epidemiol. 2010;31:1298-1300.
14. Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol. 2012;36:431-436.
15. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J. 2009;28:1047-1051.
16. Chiu CH, Michelow IC, Cronin J, et al. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J. 2011;30:273-278.
17. Kaufman DA, Zanelli S, Cantey JB, et al. Neonatal meningitis: current treatment options. In: Perlman J, ed. Neonatal Questions and Controversies: Neurology. Philadelphia, PA: Elsevier; 2012:181-201.
18. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2, pt 1):285-291.
19. Manktelow BN, Draper ES, Field DJ. Predicting neonatal mortality among very preterm infants: a comparison of three versions of the CRIB score. Arch Dis Child Fetal Neonatal Ed. 2010;95:F9-F13.
20. McCarney R, Warner J, Iliffe S, et al. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol. 2007;7:30.
21. Wendel GD Jr, Leveno KJ, Sánchez PJ, et al. Prevention of neonatal group B streptococcal disease: a combined intrapartum and neonatal protocol. Am J Obstet Gynecol. 2002;186:618-626.
22. Velaphi S, Siegel JD, Wendel GD Jr, et al. Early-onset group B streptococcal infection after a combined maternal and neonatal group B streptococcal chemoprophylaxis strategy. Pediatrics. 2003;111:541-547.
23. Stafford IA, Stewart RD, Sheffield JS, et al. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease. Obstet Gynecol. 2012;120:123-129.
24. Siegel JD, McCracken GH Jr, Threlkeld N, et al. Single-dose penicillin prophylaxis of neonatal group-B-streptococcal disease. Lancet. 1982;1:1426-1430.
25. Ibrahim OM, Polk RE. Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28:195-214.
26. Gravatt LA, Pakyz AL. Challenges in measuring antibiotic consumption. Curr Infect Dis Rep. 2013;15:559-563.
27. Berrington A. Antimicrobial prescribing in hospitals: be careful what you measure. J Antimicrob Chemother. 2010;65:163-168.
28. Mandy B, Koutny E, Cornette C, et al. Methodological validation of monitoring indicators of antibiotics use in hospitals. Pharm World Sci. 2004;26:90-95.
29. Cillessen FH, de Vries Robbé PF. Modeling problem-oriented clinical notes. Methods Inf Med. 2012;51:507-515.
30. Bayegan E, Tu S. The helpful patient record system: problem oriented and knowledge based. In: Proceedings/AMIA Annual Symposium AMIA Symposium; 2002:36-40.
31. Weintraub AS, Cadet CT, Perez R, et al. Antibiotic use in newborns with transient tachypnea of the newborn. Neonatology. 2013;103:235-240.
32. Shani L, Weitzman D, Melamed R, et al. Risk factors for early sepsis in very low birth weight neonates with respiratory distress syndrome. Acta Paediatr. 2008;97:12-15.
33. Bekhof J, Reitsma JB, Kok JH, et al. Clinical signs to identify late-onset sepsis in preterm infants. Eur J Pediatr. 2013;172:501-508.
34. Fischer JE. Physicians' ability to diagnose sepsis in newborns and critically ill children. Pediatr Crit Care Med. 2005;6(3 suppl):S120-S125.
35. Escobar GJ, Puopolo KM, Wi S, et al. Stratification of risk of early-onset sepsis in newborns ≥ 34 weeks' gestation. Pediatrics. 2014;133:30-36.
36. Jardine MA, Kumar Y, Kausalya S, et al. Reducing antibiotic use on the neonatal unit by improving communication of blood culture results: a completed audit cycle. Arch Dis Child Fetal Neonatal Ed. 2003;88:F255.
37. Engle WD, Jackson GL, Sendelbach D, et al. Neonatal pneumonia: comparison of 4 vs 7 days of antibiotic therapy in term and near-term infants. J Perinatol. 2000;20:421-426.
38. Dempsey EM, Barrington KJ. Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol. 2006;26:677-681.
39. Fanaroff JM, Fanaroff AA. Blood pressure disorders in the neonate: hypotension and hypertension. Semin Fetal Neonatal Med. 2006;11:174-181.
40. Schelonka RL, Chai MK, Yoder BA, et al. Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996;129:275-278.
41. Hsu KK, Pelton SI, Shapiro DS. Detection of group B streptococcal bacteremia in simulated intrapartum antimicrobial prophylaxis. Diagn Microbiol Infect Dis. 2003;45:23-27.
42. Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59:1-36.
43. Jackson GL, Engle WD, Sendelbach DM, et al. Are complete blood cell counts useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnionitis? Pediatrics. 2004;113:1173-1180.
44. Polin RA, Watterberg K, Benitz W, et al. The conundrum of early-onset sepsis. Pediatrics. 2014;133:1122-1123.
45. Spitzer AR, Kirkby S, Kornhauser M. Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol. 2005;25:265-269.
46. Cordero L, Ayers LW. Duration of empiric antibiotics for suspected earlyonset sepsis in extremely low birth weight infants. Infect Control Hosp Epidemiol. 2003;24:662-666.
47. Cantey JB, Sánchez PJ. Prolonged antibiotic therapy for "culture-negative" sepsis in preterm infants: it's time to stop! J Pediatr. 2011;159:707-708.
48. Hersh AL, Beekmann SE, Polgreen PM, et al. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30:1211-1217.
49. Ibrahim OM, Polk RE. Benchmarking antimicrobial drug use in hospitals. Expert Rev Anti Infect Ther. 2012;10:445-457.
50. Fouhy F, Guinane CM, Hussey S, et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother. 2012;56:5811-5820.
51. Valcourt K, Norozian F, Lee H, et al. Drug use density in critically ill children and newborns: analysis of various methodologies. Pediatr Crit Care Med. 2009;10:495-499.
52. Gerber JS, Kronman MP, Ross RK, et al. Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol. 2013;34:1252-1258.